Biosimulation Market is expected to reach around USD 9.89 Billion by 2030 at CAGR of 16.1% during the forecast period 2022-2030. In the fast-paced realm of pharmaceuticals, the biosimulation market stands as a beacon of innovation, revolutionizing drug development through the power of virtual trials. As technology continues to advance, traditional methods of drug discovery and development are...